Relevance of the degree of physical disability as a predictor of late diagnosis in leprosy: A scoping review
DOI:
https://doi.org/10.33448/rsd-v10i6.15399Keywords:
Disabled persons; Leprosy; Delayed diagnosis.Abstract
The degree of physical disability is an indicator that can determine the presence of late diagnosis and ineffective control actions. The objective of this review was to analyse the articles that presented scientific evidence on the evaluation of the degree of physical disability as a predictor of late diagnosis in leprosy. The methodology used followed the search strategy recommended by The Joanna Briggs Institute Reviewers' Manual, as well as the PRESS protocol (Peer Review of Electronic Search Strategies), the search was carried out in 3 stages, using the keywords and performed by two authors independently, in databases: Scopus, National Library of Medicines (NLM) - MEDLINE via Pubmed, Web Of Science, Cochrane Library e Biblioteca Virtual em Saúde (BVS). Of the 510 articles initially selected, an election of seven analyzed articles resulted. In the results it was observed an expressive frequency of new cases with a record of the degree of physical disability and with the multibacillary operational classification, indicators that corroborate the delay in diagnosis. The conclusion of this study shows that the degree of physical disability is relevant in the diagnosis of leprosy as an indicator and predictor of late diagnosis and possibly of hidden endemicity.
References
Alves, C. J. M., Barreto, J. A., Fogagnolo, L., Contin, L. A. & Nassif, P. W. (2010). Avaliação do grau de incapacidade dos pacientes com diagnóstico de hanseníase em serviço de dermatologia do estado de São Paulo. Revista da Sociedade Brasileira de Medicina Tropical, 43(4), 460-461. https://dx.doi.org/10.1590/S0037-86822010000400025.
Brandsma, W. J., Van Braekel, W. H. (2003). WHO disability grading: operational definitions. Leprosy Review. Inglaterra, 74(4), 366 - 373.
Brasil. (2020). Boletim Epidemiológico: Secretaria de Vigilância em Saúde, Número Especial. Ministério da Saúde: Brasília.
Brasil. (2020). Boletim Epidemiológico: Secretaria de Vigilância em Saúde, Ministério da Saúde: Brasília. Volume 51, Nº 28.
Brasil. (2016). Diretrizes para vigilância, atenção e eliminação da hanseníase como problema de saúde pública. Manual técnico-operacional Brasília: Ministério da Saúde.
Brasil. (2016). Diretrizes para vigilância, atenção e eliminação da Hanseníase como problema de saúde pública: Manual técnico-operacional. Brasília: Ministério da Saúde.
Brasil. (2019). Secretaria de Vigilância em Saúde. coordenação-geral de Desenvolvimento da Epidemiologia em Serviço: Guia de Vigilância em Saúde. Volume único. Brasília: Ministério da Saúde.
Brasil. (2019). Roteiro para uso do Sistema de Informação de Agravos de Notificação – Sinan NET para hanseníase. Manual para tabulação dos indicadores de hanseníase. Brasília: Ministério da Saúde.
Brasil. (2020). Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Estratégia Nacional para Enfrentamento da Hanseníase 2019-2022. Brasília: Ministério da Saúde.
Gómez, L., Rivera, A., Vidal ,Y., Bilbao, J., Kasang C. & Parisi, S. et al. (2018). Factors associated with the delay of diagnosis of leprosy in north-eastern Colombia: a quantitative analysis. Trop Med Int Health. 23(2):193-198. doi: 10.1111/tmi.13023.
Guerrero, M. I., Muvdi, S. & León, C. I. (2013). Retraso en el diagnóstico de lepra como factor pronóstico de discapacidad en una cohorte de pacientes en Colombia, 2000–2010. Rev Panam Salud Publica. 2013;33(2):137–43.
Oliveira, D.T.D., Sherlock, J., Melo, E.V.D., Rollemberg, K.C.V., Paixao, T.R.S.D., Abuawad, Y.G. et al. (2013). Clinical variables associated with leprosy reactions and persistence of physical impairment. Revista da Sociedade Brasileira de Medicina Tropical, 46(5), 600-604.https://doi.org/10.1590/0037-8682-0100-2013.
Organização Pan-Americana da Saúde/Organização Mundial da Saúde (OPAS/OMS). (2017). Estratégia Global para Hanseníase 2016-2020.
Pessoa de Barros, P. M. F.; Tavares, Clodis Maria; Holanda, Juliana Bento de Lima; Alves, Regina de Souza; Santos, Tâmyssa Simões dos; Arcêncio, Ricardo Alaxandre; et al. (2016). The knowledge about leprosy by health undergraduate students at the public university in county Brazilian northeast. Hansen Int. 41(1-2): 14-24.
Peters, M.D.J., Godfrey, C., McInerney, P., Munn, Z., Tricco, A.C. & Khalil, H. (2020). Revisões do escopo (versão 2020). In: Aromataris E, Munn Z (Editores). JBI Manual for Evidence Synthesis, 11. JBI. https://doi.org/10.46658/JBIMES-20-12.
Queirós, M.I., Ramos, J.A.N., Alencar, C.H.M., Monteiro, L.D., Sena, A.L. & Barbosa, J. C. (2016). Clinical and epidemiological profile of leprosy patients attended at Ceará, 2007-2011. Anais Brasileiros de Dermatologia, 91(3), 311-317. https://dx.doi.org/10.1590/abd1806-4841.20164102.
Sarkar, J., Dasgupta, A., Dutt, D. (2012). Disability among new leprosy patients, an issue of concern: an institution based study in an endemic district for leprosy in the state of West Bengal, India. Indian J Dermatol Venereol Leprol. 78(3):328-34. doi: 10.4103/0378-6323.95449.
Silva, J. S.R, Palmeira, I. P; Sá, A.M.M; Nogueira, L.M.V & Ferreira, A.M.R. (2019). Variáveis clínicas associadas ao grau de incapacidade física na hanseníase. Revista Cuidarte, 10(1), e618. https://doi.org/10.15649/cuidarte.v10i1.618
Talhari, S; Penna G.O; Gonçalves, HS; Oliveira, M.L.W. (2015) Aspectos Gerais da Hanseníase, Agente Etiológico, Transmissão, Patogenia, Classificação, Manifestação Clínica, Diagnóstico. Hanseníase. Di Livros. (5) 194-172.
WHO. World Health Organization,. (2017). The Operational Manual 2016 - Global Leprosy Estrategy, 2016-2020.
WHO. World Health Organization. (2009). Enhanced global strategy for further reduce the disease burden due to leprosy (plan period 2011-2015). Regional Office for South- East Asia, New Delhi.
WHO. World Health Organization. (2012). WHO Expert Committee on Leprosy. World Health Organization, Tech Rep Series.
WHO. World Health Organization. (2016). Global Leprosy Strategy: Accelerating towards a leprosy-free world.
WHO. World Health Organization. (2020). Global Leprosy Strategy: Overview 2021-2030.. Global Consultation NLP managers, partners and effected persons 26-30 October 2020.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Gracinda Maria Gomes Alves; Alda Graciele Cláudio dos Santos Almeida; Mirana Moura Licetti; Caroline Magna de Oliveira Costa; Karina Conceição Gomes Machado de Araújo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
